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Abstract
Background: Sniffer dogs are able to detect certain chemical particles and are suggest to be capable of helping
diagnose some medical conditions and complications, such as colorectal cancer, melanoma, bladder cancer, and
even critical states such as hypoglycemia in diabetic patients. With the global spread of COVID-19 throughout the
world and the need to have a real-time screening of the population, especially in crowded places, this study aimed
to investigate the applicability of sniffer dogs to carry out such a task.
Methods: Firstly, three male and female dogs from German shepherd (Saray), German black (Kuzhi) and Labrador
(Marco) breeds had been intensively trained throughout the classical conditioning method for 7 weeks. They were
introduced to human specimens obtained from the throat and pharyngeal secretions of participants who were
already reported positive or negative for SARS-COV-2 infection be RT-PCR. Each dog underwent the conditioning
process for almost 1000 times. In the meantime another similar condition process was conducted on clothes and
masks of COVID-19 patient using another three male and female dogs from Labrador (Lexi), Border gypsy (Sami),
and Golden retriever (Zhico) breeds. In verification test for the first three dogs, 80 pharyngeal secretion samples
consisting of 26 positive and 54 negative samples from different medical centers who underwent RT-PCR test were
in a single-blind method. In the second verification test for the other three dogs, masks and clothes of 50 RT-PCR
positive and 70 RT-PCR negative cases from different medical center were used.
Results: In verification test using pharyngeal secretion, the sniffer dogs’ detection capability was associated with a
65% of sensitivity and 89% of specificity and they amanged to identify 17 out of the 26 positive and 48 out of the
54 true negative samples. In the next verification test using patients’ face masks and clothes, 43 out of the 50
positive samples were correctly identified by the dogs. Moreover, out of the 70 negative samples, 65 samples were
correctly found to be negative. The sensitivity of this test was as high as 86% and its specificity was 92.9%. In
addition, the positive and negative predictive values were 89.6 and 90.3%, respectively.
Conclusion: Dogs are capable of being trained to identify COVID-19 cases by sniffing their odour, so they can be
used as a reliable tool in limited screening.
Keywords: Diagnosis, Screen, Sniffer dogs, Covid-19, Health, Pharyngeal secretions
© The Author(s). 2021 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License,
which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give
appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if
changes were made. The images or other third party material in this article are included in the article's Creative Commons
licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons
licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain
permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the
data made available in this article, unless otherwise stated in a credit line to the data.
* Correspondence: dr.mhdshiri@gmail.com
†Esmaeil Eskandari and Milad Ahmadi Marzaleh have had the same
contribution and both are first author.
19Researcher Toxicology Research Center, AJA University of Medical Sciences,
Tehran, Iran
Full list of author information is available at the end of the article
Eskandari et al. BMC Infectious Diseases          (2021) 21:243 
https://doi.org/10.1186/s12879-021-05939-6
Background
Since late 2019, the SARS-COV-2 virus has has started
becoming a pandemic and to the current date, it affected
millions of people and unfortunately killed hundreds of
thousaunds so far [1] including medical staffs and in-
volved all aspects of human’s life and businesses [2–4].
In the earlier phase of the pandemics, many countries
used the quarantine policy to fight the spread of disease
[5], however, the lockdowns caused a massive break-
down in economy, especially in developing and poor
countries [6, 7]. The governments had to release the
lockdowns at some points to save their economic, which
has already resulted in the second wave of the pan-
demics [8].
The prime clinical modality in the diagnosis of
COVID-19 seems to be Computed Tomography (CT-
scan) and the golden standard method is the Polymerase
Chain Reaction (PCR) test, that both of have limitations
[9]. Studies showed that the PCR test for COVID-19 re-
sulted in different sensitivity and specificity values across
the world based on different factors including methods
of obtaining samples [10–12]. Moreover, CT-scan re-
quires radiation and raises the risk of multiple morbid-
ities, including malignancies. Furthermore, both tests are
neither suitable for public screening, nor are they avail-
able in all areas and settings [13, 14].
The meticulous canine olfactory system is well-known,
which is equipped with an extensive scent epithelium
(170 cm2 and 17 times greater than humans) as well as a
large number of olfactory receptors (beyond 200 million
receptors in comparison to 5 million in humans) [15,
16]. This ability is currently and commonly being used
in detecting explosive materials, drugs, and dead bodies.
The use of sniffer dogs in medical literature dates back
to a case report in 1989, in which a dog could smell the
mole of its owner [17]. When she wore a skirt, the dog
wanted to bite one specific mole, while was indifferent
about other moles on her body. The owner became sus-
picious and consulted a dermatologist, who came up
with the diagnosis of melanoma. Since then many stud-
ies focused on the utility of dog olfaction for screening
or diagnosis of different medical condition. The possible
use of dogs in the diagnosis of some diseases such as
malignancies, diabetes, Parkinson’s, seizures, and certain
hormonal and enzymatic defects has been investigated
by many studies [17–28]. It is commonly believed that
dogs can be trained to detect the odour of particular
molecules and compounds that changed during diseases.
These odours are mainly believed to come from Volatile
Organic Compounds (VOCs), produced by altered
biochemical interactions inside body in the presence of
malignancies, inflammations, infections, and other
pathological events. Metabolic changes in the body re-
sult in a set of certain odours that may be recognisable
for animals, specifically for dogs, as they have an
extremly powerful olfactory system and also a very com-
plex and unique analytical mechanism for interpretation
of odours at their molecular levels [24]. Accordingly,
COVID-19 should not be an exception. At the present
time, the diagnosis of Covid-19 is based on sophisticated
biochemical and genetic tests and CT-scan imaging.
These modalities are relatively expensive and require ac-
curate medical equipment, trained staffs and interpret-
ation experts, which are not available everywhere across
the world. Thus, the golden time may be lost for detect-
ing affected people to cut the chain of transmission or to
start the suitable treatments for affected people [29]. It
is suggested that the use of trained dogs leads to earlier
detection of infected persons at a lower cost. This helps
separate asymptomatic carriers quickly as each dog has a
screening capacity of 250 samples per hour, which is ef-
fective enough to be used in certain places to control
transmission of the disease.
According to the recommendations of the World
Health Organization (WHO), the most critical issue in
adopting strategies and policies to mitigate the spread of
the disease is the ability of screening large number of
people, which is either impossible or difficult to do using
hitec devices, especially in low-resource countries and
settings. So it may be hypothesized that a defined popu-
lation or environment can be quickly screened at a lower
cost by using trained dogs. Therefore, this study aims to




This study was based on a hypothesis that assumes the
sniffer dogs are able to detect metabolic changes in hu-
man body, which is caused by the pathological activities
of SARS-Cov-2 virus. For this purpose, we designed a
training process to condition six male and female dogs
from five different breeds including German shepherd,
German black, Labrador, Golden retriever, and Border
gypsy. The study was conducted into two different train-
ing sectors. One study on participants’ pharyngeal secre-
tions samples tested by RT-PCR as the gold standard
method to detect positive and negative cases and an-
other study on participants’ face masks and clothes
using, who were already tested positive or negative using
RT-PCR. Patents were from cases hospitalized in differ-
ent ICUs across city of Tehran. Negative cases were
healthy individuals who were RT-PCR negative for
SARS.CoV-2 virus. Finally, the verification test was car-
ried out in a single-blind process.
This study was approved by Iran’s Ministry of Health,
Treatment, and Medical Education (IR.AJAUMS.-
REC.139.055). All dog trainers were fully equipped with
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proper Personal Protection Equipment (PPE) when
working with dogs and the samples.
Sniffer dogs’ details
Study dogs belonged to the SK9 Dogs Training School.
Each dog’s training background, age, and gender had to
be taken into account. Since there was no evidence on
the success rate of species for detecting the COVID-19
virus, our study dogs were selected from different spe-
cies and ages. The dogs’ characteristics are shown in
Table 1.
Dog training
Three dogs including one German shepherd, one
Labrador, and one Border gypsy were intensively
trained by the classical conditioning method for 7
weeks [30–32]. They were introduced to the
pharyngeal secretions of both and COVID-19 pa-
tients and healthy individuals. The specimens were
daily transported from the hospital laboratories to
the training site under safe and standard conditions.
These samples were placed in groups of 10 consist-
ing of one to three positive samples for COVID-19
inside a dogs training wheel. Positive samples were
obtained from the patients admitted to the ICU and
were taken from both male and female patients at
different ages before and after taking medicines. It
should be noted that some patients were completely
healthy before contracting COVID-19, while some
had underlying diseases such as diabetes, coronary
diseases, heart failure, renal failure, respiratory dis-
ease such as asthma and Chronic Obstructive Pul-
monary Disease (COPD), and Senecavirus A (SVA).
In the second section of the study, the training set
included face masks and clothes and another three
dog were trained using 1300 clothes and 1300 face
masks of Covid-19 patients. These stuffs had been
worn for 24 h before being used as samples. The
control samples for this section included the same
hospital clothes and masks from the patients who
were admitted in the hospital but were proven by
RT-PCR to be not COVID-19 case.
Safety and protection protocols
Testing
Before startingproject, all training team members as well
as dogs were tested for COVID-19 using RT-PCR
method to make sure that they were not themselves in-
fected by the virus. In the course of the study also, the
training team members were tested frequently on days 1,
21, 35, and 49. Two weeks after the final verifications, all
team members were tested again to make sure they were
infected during the past week. Also all protection mea-
sures were taken to protect the dogs. Dogs were quaran-
tined for 2 weeks after the testing events. They
underwent RT-PCR tests 2 weeks before and after the
testing event and all were negative for SAR-CoV-2
contamination.
Personal protection
All team members were highly required to use th PPE,
face masks, and shields similar to those used in ICUs.
Quarantine
All training team members stayed 24 h/7 days in the
training site during the whole study period of time.
Samples delivery
Pharyngeal secretion samples, face masks, and clothes
were safely delivered to the site in sealed boxes.
Sanitizing
Training site, training equipment and the dormitory of
the team were sanitized twice a day during the training
period.
Dogs condition
The dogs were kept in standard cages under standard
conditions and were fed with high-quality dog foods. It
should be noted that no forceful training equipment
were utilized.
Verification test
In late April 2020, following 7 weeks of intensive train-
ing where each dog underwent the training process for
averagely about 1000 times, and nearly 120 tests were
performed during the course, the verifying tests were
conducted for both groups of dogs. For the verification
test of the first group of dogs, 80 samples of pharyngeal
secretions that 26 and 54 were positive and negative re-
spectively (Negative samples were from healthy individ-
uals) were used in a single-blind fashion. Fr the second
group of the dogs 120 samples consisting of clothes and
face masks were used that of them 50 and 70 were posi-
tive and negative respectively. Negative cases were iden-
tified by PCR. However, the negative symptoms of the
subjects were checked 2 weeks before and after the test.
Table 1 Dogs’ characteristics
Name Age (year) Gender Species
Lexi 1 Female Labrador
Sami 2 Male Border gypsy
Saray (SY) 2 Female German shepherd
Kuzhi (KZH) 1.5 Female German black
Marco (MRC) 1.5 Male Labrador
Zhico 3 Male Golden retriever
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Notable to mention that the samples were taken from
different medical centers and people with various levels
of disease severity. The samples were used from the
population of Tehran in Iran, and considering that
Tehran is a homogeneous sample of the whole country
and to be considered socio-economic; positive samples
were collected from several different hospitals for max-
imum diversity.
At the end of the study, none of the dogs had COVID-
19 and were completely healthy.
Statistical analysis
Epidemiological and statistical tests including sensitivity
or True Positive Rate (TPR), specificity or True Negative
Rate (TNR), positive condition, negative condition, False
Negative Rate (FNR), False Positive Rate (FPR), Positive
and Negative Likelihood Ratios (LR+/LR-) were per-
formed and the data were analyzed using the SPSS soft-
ware, version 23.
Result
In sector 1 of the study, after completing training
process, dogs were introduced to the throat and naso-
pharengeal samples. Dogs were able to identify positive
samples among all type of samples with an accuracy of
over 80%. In the verification test, 80 samples in test
tubes were used in eight sets of ten (both positive and
negative) includig 26 positive samples that dogs identi-
fied 17 correctly, and 54 negative samples that surpris-
ingly dogs identified 48 of them correctly. Nevertheless,
the performances of the three trained dogs were slightly
different. The German shepherd Saray (SY) and), the
German black dog Kuzhi (KZH) successfully identified
six out of the ten positive samples in a set of 30 positive
and negative samples. The third dog in this experiment
was Marco (MRC), a Labrador that identified five posi-
tive samples out of a set of 20 that of them 6 and 14
were positive and negative respectively (Table 2).
In average, three dogs detected 17 out of the 26 posi-
tive samples making a sensitivity of 65%. Moreover,
averagely the correct detection rate of the negative sam-
ples was 89% for three dogs (Table 3) (Fig. 1).
In the sector 2 of the study, the testing set included 50
positive (clothes and masks from RT-PCR positive pa-
tients) and 70 control (from RT-PCR negative people)
samples. Out of the 50 positive samples, 43 were cor-
rectly identified by Lexi, Sami and Zhico. Moreover, out
of the 70 negative samples, 65 were correctly detected
by them. The sensitivity of this experiment was as high
as 86% with a specificity of 92.9%. Additionally, the posi-
tive and negative predictive values were found to be 89.6
and 90.3%, respectively (Table 4).
Discussion
First of all it must be mentioned that due to the obser-
vance of appropriate protection protocols, neither the
dogs nor the trainers were infected with COVID-19
during 10 weeks of training, which was a great
achievement.
Since the historical case report by Williams et al. in
1989 [17], there have been few experiments in the utility
of the canine olfactory system for medical purposes.
These experiments were mostly related to the detection
of ovarian, prostate, colorectal, and lung cancer [20, 22,
23, 26, 27, 33, 34]. However, the use of canine olfactory
system in other areas such as infectious diseases has
been rarely studied. The current study aimed to investi-
gate the applicability of canine olfactory system in
detecting COVID-19 cases and carriers of SARS-C0v_2.
In this regard, a recent pre-print paper showed the effi-
cacy of dogs in differentiating the COVID-19 positive
and negative cases using armpit sweat [35]. There was a
study by Jendry et al. that started after ours. Their aim
was to detect Covid-19 samples using dogs and They
showed that dogs were able to correctly detect 94% of
positive and negative samples. Their sensitivity and spe-
cificity were 82.63 and 96.35% respectively [36]. They
used larger number of samples in verification test,
howere all RT-PCR tests were performed by themselves.
In our study, the RT-PCR tests were run by hospital la-
boratories to avoid the possible bias.
Regarding the results we have achieved, it can be
declared that his research has successfully proven a
the concept of the presence of a specific and trace-
able odour in people with COVID-19 disease. In the
Table 2 Performances of different dogs









conditionTrue positive False negative False positive True negative
SY 6 4 3 17 9 10 21 20
KZH 6 4 2 18 8 10 22 20
MRC 5 1 1 13 6 6 14 14
Total 17 9 6 48 23 26 57 54
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sector 1 of the study, the dogs successfully distin-
guished over 65% of the positive specimens and 89%
of the negative samples and inthe sector 2 where
clothes and masks of participants were used, dogs
could correctly detect 86% of the positive and 92.9%
of the negative samples. It should be noted that the
samples were taken from people with different clin-
ical conditions on different days and from different
hospitals to minimise the possible environmental ef-
fects. It can be certainly claimed that the presence
of SARS-CoV-2 virus in human body leads to pro-
duction and release of a specific odour, which does
not exist innegative sample. We assume that a spe-
cific chain of chemical and metabolic reactions
causes that specific odour in affected people with
Covid-19.
In the sector 1 of the study, the obtained sensitivity
and specificity were 65 and 89% respectively, however
in the sector 2, these values were as high as 86 and
92.9%, respectively, which are somehow comparable
to those of laboratory diagnostic kits such as RT-PCR
[37, 38]. As we currently know, there are at least
3481 VOCs in human breath, so we hope by using
them it can be possibe to design biosensors and
electronic noses to detect Covid-19. Currently, it is
already proven that the VOCs are associated with sev-
eral malignancies. For example, 4-methyl decane,
dodecane, and undecane have been reported to be as-
sociated with malignant melanoma [39].
In terms of diagnosis speed, dogs are real-time detec-
tors that are highly required in the setting of pandemics.
Furthermore, dogs are supposed to have better perform-
ance with more intense training. Thus, such detecting
dogs can be used to identify suspicious COVID-19 cases
in places with a high population density, such as air-
ports, passenger terminals, and important national
centers.
We suggest there were some limitations with our
study. Firstly we did not have a prevalence rate. Secondly
it was not possible for us to double check the people
who were RT-PCR negative (our controls) by a second
RT-PCR test. Thirdly, at the nearly end of the dog train-
ing phase, Iran managed to substantially cut the number
of new cases, so we were unable to raise the number of
samples in regard of achieving statistically stronger re-
sults. Lastly if we could reduce the false negatives rate to
a figure nearly zero, then the sensitivity would largely
increase.
Table 3 Statistical results of the dogs’ performance
Sensitivity or true











SY 60% 40% 15% 85% 4 0.4706
KZH 60% 40% 10% 90% 6 0.4444
MRC 83% 17% 7% 93% 11.667 0.1795
Total 65% 35% 11% 89% 5.8846 0.3894
Fig. 1 Statistical results of the dogs’ performances
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Conclusion
Dogs can be trained to identify people with COVID-19
disease and can be used as a reliable tool in limited
screening programs. This study was a limited experience
and could serve as a basis for other researchers to in-
spire. Identification of the VOCs associated with
COVID-19,provides a great opportunity todevelop bio-
sensors for screening of mass population.
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